Role of CD8 T Lymphocyte Cells: Interplay with Stromal Cells in Tumor Microenvironment

Overview

Journal Acta Pharm Sin B

Publisher Elsevier

Specialty Pharmacology

Date 2021 Jul 5

PMID 34221857

Citations 40

Authors

Qin Xie

Jian Ding

Yi Chen

Affiliations

Soon will be listed here.

Abstract

CD8 T lymphocytes are pivotal cells in the host response to antitumor immunity. Tumor-driven microenvironments provide the conditions necessary for regulating infiltrating CD8 T cells in favor of tumor survival, including weakening CD8 T cell activation, driving tumor cells to impair immune attack, and recruiting other cells to reprogram the immune milieu. Also in tumor microenvironment, stromal cells exert immunosuppressive skills to avoid CD8 T cell cytotoxicity. In this review, we explore the universal function and fate decision of infiltrated CD8 T cells and highlight their antitumor response within various stromal architectures in the process of confronting neoantigen-specific tumor cells. Thus, this review provides a foundation for the development of antitumor therapy based on CD8 T lymphocyte manipulation.

Citing Articles

Therapeutic Vaccines for Hematological Cancers: A Scoping Review of This Immunotherapeutic Approach as Alternative to the Treatment of These Malignancies.

Mathias F, Carvalho M, Ruiz J Vaccines (Basel). 2025; 13(2).

PMID: 40006660 PMC: 11860334. DOI: 10.3390/vaccines13020114.

The role of tumor types in immune-related adverse events.

Xu Q, Hu J, Wang Y, Wang Z Clin Transl Oncol. 2024; .

PMID: 39738878 DOI: 10.1007/s12094-024-03798-6.

Advancements in immunotherapy for colorectal cancer treatment: a comprehensive review of strategies, challenges, and future prospective.

Kaviyarasan V, Das A, Deka D, Saha B, Banerjee A, Sharma N Int J Colorectal Dis. 2024; 40(1):1.

PMID: 39731596 PMC: 11682016. DOI: 10.1007/s00384-024-04790-w.

Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes.

Li X, Wang X, Yu F, Li Z, Chen D, Qi Y Transl Oncol. 2024; 52():102232.

PMID: 39647324 PMC: 11667168. DOI: 10.1016/j.tranon.2024.102232.

Effects of fermented L. on the profile of hematology, clinical chemistry, and circulatory CD4+/CD8+ in Sprague Dawley rats.

Wijayanti A, Prakoso Y, Isla K Open Vet J. 2024; 14(9):2475-2483.

PMID: 39553756 PMC: 11563629. DOI: 10.5455/OVJ.2024.v14.i9.36.

References

Mpakali A, Stratikos E . The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy. Cancers (Basel). 2021; 13(1). PMC: 7796214. DOI: 10.3390/cancers13010134. View

Mariathasan S, Turley S, Nickles D, Castiglioni A, Yuen K, Wang Y . TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018; 554(7693):544-548. PMC: 6028240. DOI: 10.1038/nature25501. View

Massi D, Romano E, Rulli E, Merelli B, Nassini R, De Logu F . Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients. Eur J Cancer. 2017; 78:70-81. DOI: 10.1016/j.ejca.2017.03.012. View

Li X, Xiang Y, Li F, Yin C, Li B, Ke X . WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment. Front Immunol. 2019; 10:2293. PMC: 6775198. DOI: 10.3389/fimmu.2019.02293. View

Lines J, Sempere L, Broughton T, Wang L, Noelle R . VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. Cancer Immunol Res. 2014; 2(6):510-7. PMC: 4085258. DOI: 10.1158/2326-6066.CIR-14-0072. View

Zhang N, Bevan M . CD8(+) T cells: foot soldiers of the immune system. Immunity. 2011; 35(2):161-8. PMC: 3303224. DOI: 10.1016/j.immuni.2011.07.010. View

Scott A, Dundar F, Zumbo P, Chandran S, Klebanoff C, Shakiba M . TOX is a critical regulator of tumour-specific T cell differentiation. Nature. 2019; 571(7764):270-274. PMC: 7698992. DOI: 10.1038/s41586-019-1324-y. View

Blagih J, Zani F, Chakravarty P, Hennequart M, Pilley S, Hobor S . Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses. Cell Rep. 2020; 30(2):481-496.e6. PMC: 6963783. DOI: 10.1016/j.celrep.2019.12.028. View

Cohen N, Shani O, Raz Y, Sharon Y, Hoffman D, Abramovitz L . Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. Oncogene. 2017; 36(31):4457-4468. PMC: 5507301. DOI: 10.1038/onc.2017.65. View

10.

Huang Y, Zhu C, Kondo Y, Anderson A, Gandhi A, Russell A . CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature. 2014; 517(7534):386-90. PMC: 4297519. DOI: 10.1038/nature13848. View

11.

Guo G, Yu M, Xiao W, Celis E, Cui Y . Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity. Cancer Res. 2017; 77(9):2292-2305. PMC: 5465961. DOI: 10.1158/0008-5472.CAN-16-2832. View

12.

Seo H, Chen J, Gonzalez-Avalos E, Samaniego-Castruita D, Das A, Wang Y . TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8 T cell exhaustion. Proc Natl Acad Sci U S A. 2019; 116(25):12410-12415. PMC: 6589758. DOI: 10.1073/pnas.1905675116. View

13.

Kallies A, Zehn D, Utzschneider D . Precursor exhausted T cells: key to successful immunotherapy?. Nat Rev Immunol. 2019; 20(2):128-136. DOI: 10.1038/s41577-019-0223-7. View

14.

Lee W, Lee Y, Choi M, Yun K, Won C, Lee M . Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes. J Am Acad Dermatol. 2019; 81(1):219-227. DOI: 10.1016/j.jaad.2019.03.012. View

15.

Hamzah J, Jugold M, Kiessling F, Rigby P, Manzur M, Marti H . Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature. 2008; 453(7193):410-4. DOI: 10.1038/nature06868. View

16.

Koyama S, Akbay E, Li Y, Aref A, Skoulidis F, Herter-Sprie G . STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment. Cancer Res. 2016; 76(5):999-1008. PMC: 4775354. DOI: 10.1158/0008-5472.CAN-15-1439. View

17.

Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A . CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol. 2002; 3(11):1097-101. DOI: 10.1038/ni846. View

18.

Cremasco V, Astarita J, Grauel A, Keerthivasan S, MacIsaac K, Woodruff M . FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors. Cancer Immunol Res. 2018; 6(12):1472-1485. PMC: 6597261. DOI: 10.1158/2326-6066.CIR-18-0098. View

19.

Araki K, Turner A, Shaffer V, Gangappa S, Keller S, Bachmann M . mTOR regulates memory CD8 T-cell differentiation. Nature. 2009; 460(7251):108-12. PMC: 2710807. DOI: 10.1038/nature08155. View

20.

LeMaoult J, Caumartin J, Daouya M, Favier B, Le Rond S, Gonzalez A . Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood. 2006; 109(5):2040-8. DOI: 10.1182/blood-2006-05-024547. View